Summary
The C6 glioma cell line contains nerve growth factor (NGF) which can be released into the medium. Treatment of the cells with beta-adrenoceptor agonists resulted in increased content of NGF in both the cells and the medium within a few hours, whereas alpha-adrenoceptor agonists were ineffective. The response was blocked by beta- but not alpha-adrenoceptor antagonists. The increase of the NGF content of glioma cells appeared to be mediated by an elevation of cyclic AMP or GMP. The addition to the cell cultures of other putative neurotransmitters failed to change the content of either NGF or cyclic AMP. These results are discussed with respect to a model for adrenergic neuron-glial interactions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andres, R. Y., Rubin, J. S., Bradshaw, R. A.: Specific nuclear binding of nerve growth factor. Trans. Amer. Soc. Neurochem. 8, 190 (1977)
Banerjee, S. P., Snyder, S. H., Cuatrecasas, P., Greene, L. A.: Binding of nerve growth factor receptor in sympathetic ganglia. Proc. Natl. Acad. Sci U.S.A. 70, 2519–2523 (1973)
Browning, E. T., Schwartz, J. P., Breckenridge, B. McL.: Norepinephrine-sensitive properties of C-6 astrocytoma cells. Mol. Pharmacol. 10, 162–174 (1974)
Burnham, P., Raiborn, C., Varon, S.: Replacement of nerve growth factor by ganglionic non-neuronal cells for the survival in vitro of dissociated ganglionic neurons. Proc. Natl. Acad. Sci. U.S.A. 69, 3556–3560 (1972)
Clark, R. B., Perkins, J. P.: Regulation of adenosine-3′,5′-monophosphate concentration in cultured human astrocytoma cells by catecholamines and histamine. Proc. Natl. Acad. Sci. U.S.A. 68, 2757–2760 (1971)
Costa, E., Kurosawa, A., Guidotti, A.: Activation and nuclear translocation of protein kinase during transsynaptic induction of tyrosine-3-monooxygenase. Proc. Natl. Acad. Sci. U.S.A. 73, 1058–1062 (1976)
Cullen, S. E., Schwartz, B. D.: An improved method for isolation of H-2 and Ia alloantigens with immunoprecipitation induced by protein-A bearing staphylococci. J. Immunology 117, 136–142 (1976)
De Vellis, J., Brooker, G.: Induction of enzymes by glucocorticoids and catecholamines in a rat glial cell line. In: Tissue culture of the nervous system (G. Sato, ed.), pp. 231–245. New York: Plenum Press 1973
Frazier, W. A., Boyd, L. F., Bradshaw, R. A.: Properties of the specific binding of 125I-nerve growth factor to responsive peripheral neurons. J. Biol. Chem. 249, 5513–5519 (1974)
Gilman, A. G., Nirenberg, M.: Effect of catecholamines on the adenosine-3′,5′-cyclic monophosphate concentrations of clonal satellite cells of neurons. Proc. Natl. Acad. Sci. U.S.A. 68, 2165–2168 (1971)
Hendry, I. A., Stoeckel, K., Thoenen, H., Iversen, L.: The retrograde axonal transport of nerve growth factor. Brain Res 68, 103–121 (1974)
Herrup, K., Shooter, E. M.: Properties of the β-nerve growth factor receptor of avian dorsal root ganglia. Proc. Natl. Acad. Sci. U.S.A. 70, 3884–3888 (1973)
Hier, D. B., Arnason, B. G. W., Young, M.: Studies on the mechanism of action of nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 69, 2268–2272 (1972)
Longo, A. M., Penhoet, E. E.: Nerve growth factor in rat glioma cells. Proc. Natl. Acad. Sci. U.S.A. 71, 2347–2349 (1974)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin Phenol reagent. J. Biol. Chem. 193, 265–275 (1951)
Monard, D., Stoeckel, K., Goodman, R., Thoenen, H.: Distinction between nerve growth factor and glial factor. Nature 258, 444–445 (1975)
Murphy, R. A., Oger, J., Saide, J. D., Blanchard, M. H., Arnason, B. G. W., Hogan, C., Pantazis, N. J., Young, M.: Secretion of nerve growth factor by central nervous system glioma cells in culture. J. Cell. Biol. 72, 769–773 (1977)
Opler, L. A., Makman, M. H.: Mediation by cyclic AMP of hormone-stimulated glycogenolysis in cultured rat astrocytoma cells. Biochem. Biophys. Res. Commun. 46, 1140–1145 (1972)
Robinson, G. A., Butcher, R. W., Sutherland, E. W.: Cyclic AMP. New York: Plenum Press 1971
Schubert, D., Tarikas, H., LaCorbiere, M.: Neurotransmitter regulation of adenosine-3′,5′-monophosphate in clonal nerve, glia and muscle cell lines. Science 192, 471–472 (1976)
Schwartz, J. P.: Catecholamine-mediated elevation of cyclic GMP in the rat C-6 glioma cell line. J. Cycl. Nucl. Res. 2, 287–296 (1976)
Schwartz, J. P., Passonneau, J. V.: Cyclic AMP-mediated induction of the cyclic AMP phosphodiesterase of C6 glioma cells. Proc. Natl. Acad. Sci. U.S.A. 71, 3844–3848 (1974)
Schwartz, J. P., Morris, N. R., Breckenridge, B. McL.: Adenosine-3′,5′-monophosphate in glial tumor cells: Alterations by 5-bromodeoxyuridine. J. Biol. Chem. 248, 2699–2704 (1973)
Schwartz, J. P., Chuang, D.-M., Costa, E.: Increase in nerve growth factor content of C6 glioma cells by the activation of a β-adrenergic receptor. Brain. Res. 1977
Shooter, E. M., Berger, E. A.: The biosynthesis of nerve growth factor. Trans. Amer. Soc. Neurochem. 8, 63 (1977)
Stoeckel, K., Schwab, M., Thoenen, H.: Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: A biochemical and morphological study. Brain Res. 89, 1–14 (1975)
Varon, S., Nomura, J., Shooter, E. M.: The isolation of the mouse nerve growth factor in a high molecular weight form. Biochemistry 6, 2202–2209 (1967)
Varon, S., Raiborn, C., Norr, S.: Association of antibody to nerve growth factor with ganlionic non-neurons (glia) and consequent interference with their neuron-supportive action. Exp. Cell. Res. 88, 247–256 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schwartz, J.P., Costa, E. Regulation of nerve growth factor content in C6 glioma cells by β-adrenergic receptor stimulation. Naunyn-Schmiedeberg's Arch. Pharmacol. 300, 123–129 (1977). https://doi.org/10.1007/BF00505042
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00505042